BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7672873)

  • 1. Upregulated expression of peripheral serotonergic receptors in migraine and cluster headache by sumatriptan.
    Martelletti P; Stirparo G; Rinaldi C; Giacovazzo M
    Int J Clin Pharmacol Res; 1994; 14(5-6):165-75. PubMed ID: 7672873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the unresponsiveness to sumatriptan in cluster headache related to an alteration in the 5-HT receptors?
    Stirparo G; Fusco BM; Giacovazzo M; Rinaldi C; Martelletti P
    Int J Clin Pharmacol Res; 1993; 13(5):247-53. PubMed ID: 7515379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cluster headache: a clinical model of immunologic receptor pathology?].
    Giacovazzo M; Martelletti P
    Ann Ital Med Int; 1992; 7(3 Suppl):33S-37S. PubMed ID: 1338421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sumatriptan ++ in the treatment of migraine and cluster headache].
    Láinez JM; Monzón MJ
    Rev Neurol; 1995; 23 Suppl 2():S166-78. PubMed ID: 7497282
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of migraine with special reference to sumatriptan].
    Baumhackl U
    Wien Med Wochenschr; 1994; 144(5-6):110-3. PubMed ID: 8053215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The way to serotonergic use and abuse in migraine.
    Nicolodi M; Del Bianco PL; Sicuteri F
    Int J Clin Pharmacol Res; 1997; 17(2-3):79-84. PubMed ID: 9403359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of the peripheral serotoninergic pathways in migraine: a proposal for an experimental model.
    Martelletti P; Stirparo G; Rinaldi C; Fusco BM
    Cephalalgia; 1994 Feb; 14(1):11-5; discussion 4. PubMed ID: 7515328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.
    Dahlöf C; Maassen Van Den Brink A
    Headache; 2012 Apr; 52(4):707-14. PubMed ID: 22444161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan succinate : pharmacokinetics of different formulations in clinical practice.
    Lionetto L; Negro A; Casolla B; Simmaco M; Martelletti P
    Expert Opin Pharmacother; 2012 Nov; 13(16):2369-80. PubMed ID: 23013035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A putative 5-HT central feedback in migraine and cluster headache attacks.
    Salmon S; Bonciani M; Fanciullacci M; Marianelli L; Michelacci S; Sicuteri F
    Adv Neurol; 1982; 33():265-74. PubMed ID: 7055005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin receptors and headache.
    Raskin NH
    N Engl J Med; 1991 Aug; 325(5):353-4. PubMed ID: 1647497
    [No Abstract]   [Full Text] [Related]  

  • 13. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.
    Villalón CM; Centurión D; Valdivia LF; De Vries P; Saxena PR
    Proc West Pharmacol Soc; 2002; 45():199-210. PubMed ID: 12434581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug management of adult vascular headaches (migraine and cluster headache): Part I--Treatment of the acute attack.
    Damasio H
    Iowa Med; 1984 Nov; 74(11):490-2. PubMed ID: 6511281
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology and efficacy of eletriptan for the treatment of migraine attacks.
    Diener HC; McHarg A
    Int J Clin Pract; 2000 Dec; 54(10):670-4. PubMed ID: 11221281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis.
    Sakai Y; Dobson C; Diksic M; Aubé M; Hamel E
    Neurology; 2008 Feb; 70(6):431-9. PubMed ID: 18250288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present and future of 5-HT receptor agonists as antimigraine drugs.
    Pauwels PJ; John GW
    Clin Neuropharmacol; 1999; 22(3):123-36. PubMed ID: 10367177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels.
    Bouchelet I; Cohen Z; Case B; Séguéla P; Hamel E
    Mol Pharmacol; 1996 Aug; 50(2):219-23. PubMed ID: 8700126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.